Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syft Technologies is a world leader in real-time, direct injection mass spectrometry, specializing in Selected Ion Flow Tube Mass Spectrometry (SIFT-MS). The company provides high-sensitivity analytical instruments that enable the rapid, chromatography-free detection of volatile organic compounds (VOCs) and trace gases at parts-per-trillion levels. Its technology is extensively applied in the pharmaceutical industry for residual solvent analysis, impurity detection, and CDMO quality control, as well as in environmental monitoring, semiconductor manufacturing, and clinical breath research. Headquartered in New Zealand, Syft serves a global market including major pharmaceutical and technology firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syft.